- Home
- MPTI vs TLSI Comparison
MPTI vs TLSI Comparison
Compare MPTI & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPTI
- TLSI
- Stock Information
- Founded
- MPTI 1965
- TLSI 2010
- Country
- MPTI United States
- TLSI United States
- Employees
- MPTI N/A
- TLSI N/A
- Industry
- MPTI
- TLSI Medical Specialities
- Sector
- MPTI
- TLSI Health Care
- Exchange
- MPTI Nasdaq
- TLSI Nasdaq
- Market Cap
- MPTI 147.2M
- TLSI 160.4M
- IPO Year
- MPTI N/A
- TLSI N/A
- Fundamental
- Price
- MPTI $51.47
- TLSI $5.74
- Analyst Decision
- MPTI
- TLSI Strong Buy
- Analyst Count
- MPTI 0
- TLSI 6
- Target Price
- MPTI N/A
- TLSI $11.75
- AVG Volume (30 Days)
- MPTI 75.6K
- TLSI 57.4K
- Earning Date
- MPTI 05-06-2025
- TLSI 05-14-2025
- Dividend Yield
- MPTI N/A
- TLSI N/A
- EPS Growth
- MPTI 107.03
- TLSI N/A
- EPS
- MPTI 2.65
- TLSI N/A
- Revenue
- MPTI $49,012,000.00
- TLSI $29,431,000.00
- Revenue This Year
- MPTI $11.76
- TLSI $55.08
- Revenue Next Year
- MPTI $7.64
- TLSI $50.75
- P/E Ratio
- MPTI $19.42
- TLSI N/A
- Revenue Growth
- MPTI 19.05
- TLSI 58.99
- 52 Week Low
- MPTI $23.00
- TLSI $3.50
- 52 Week High
- MPTI $71.10
- TLSI $10.24
- Technical
- Relative Strength Index (RSI)
- MPTI 62.04
- TLSI 59.91
- Support Level
- MPTI $47.93
- TLSI $5.23
- Resistance Level
- MPTI $51.99
- TLSI $5.66
- Average True Range (ATR)
- MPTI 4.84
- TLSI 0.34
- MACD
- MPTI 0.96
- TLSI 0.03
- Stochastic Oscillator
- MPTI 91.18
- TLSI 92.94
About MPTI M-tron Industries Inc.
M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.